Advanced search
Start date
Betweenand

Immunometabolism as new approach to development of "natural adjuvants" that induce regulatory responses

Grant number: 19/13598-8
Support Opportunities:Scholarships abroad - Research Internship - Doctorate
Start date: December 01, 2019
End date: November 30, 2020
Field of knowledge:Health Sciences - Pharmacy
Principal Investigator:Dulcineia Saes Parra Abdalla
Grantee:Gustavo Luis Tripodi
Supervisor: Daniel Francisco Jacon Ketelhuth
Host Institution: Faculdade de Ciências Farmacêuticas (FCF). Universidade de São Paulo (USP). São Paulo , SP, Brazil
Institution abroad: Karolinska Institutet, Sweden  
Associated to the scholarship:17/06568-0 - Immunization of LDLr - / - mice with electronegative LDL mimetic peptides: a potential therapeutic strategy for atherosclerosis, BP.DR

Abstract

The tryptophan metabolism through the kynurenine pathway is pivotal to the polarization of regulatory T cell. Not only tryptophan but also other metabolic pathways such as glycolysis have been shown to modulate immune cell responses. It is our aim to investigate whether tryptophan modulation and the energy metabolism on immune cells can act as "natural adjuvants" and improve anti-atherosclerotic responses induced by experimental vaccines using LDL- mimotopes in vitro.

News published in Agência FAPESP Newsletter about the scholarship:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
ARORA, AASTHA; TRIPODI, GUSTAVO LUIS; KAREINEN, ILONA; BERG, MARTIN; FORTEZA, MARIA JOSEFA; GISTERA, ANTON; GRIEPKE, SILKE; CASAGRANDE, FELIPE BECCARIA; MARTINS, JOILSON O.; ABDALLA, DULCINEIA SAES PARRA; et al. Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v. 23, n. 9, p. 17-pg., . (19/13598-8, 20/03175-0)